Related references
Note: Only part of the references are listed.The molecular basis of antimalarial drug resistance in Plasmodium vivax
Lucas E. Buyon et al.
INTERNATIONAL JOURNAL FOR PARASITOLOGY-DRUGS AND DRUG RESISTANCE (2021)
Efficacy of directly-observed chloroquine-primaquine treatment for uncomplicated acute Plasmodium vivax malaria in northeast Myanmar: A prospective open-label efficacy trial
Shiling Xu et al.
TRAVEL MEDICINE AND INFECTIOUS DISEASE (2020)
Recrudescence, Reinfection, or Relapse? A More Rigorous Framework to Assess Chloroquine Efficacy for Plasmodium vivax Malaria
Jean Popovici et al.
JOURNAL OF INFECTIOUS DISEASES (2019)
Doses of chloroquine in the treatment of malaria by Plasmodium vivax in patients between 2 and 14 years of age from the Brazilian Amazon basin
Luann Wendel Pereira de Sena et al.
MALARIA JOURNAL (2019)
Comparison of the Cumulative Efficacy and Safety of Chloroquine, Artesunate, and Chloroquine-Primaquine in Plasmodium vivax Malaria
Cindy S. Chu et al.
CLINICAL INFECTIOUS DISEASES (2018)
The effect of chloroquine dose and primaquine on Plasmodium vivax recurrence: a WorldWide Antimalarial Resistance Network systematic review and individual patient pooled meta-analysis
Robert J. Commons et al.
LANCET INFECTIOUS DISEASES (2018)
Mobile population dynamics and malaria vulnerability: a modelling study in the China-Myanmar border region of Yunnan Province, China
Tian-Mu Chen et al.
INFECTIOUS DISEASES OF POVERTY (2018)
Low uptake of malaria testing within 24h of fever despite appropriate health-seeking among migrants in Myanmar: a mixed-methods study
Kyaw Thu Hein et al.
MALARIA JOURNAL (2018)
Clinical and molecular surveillance of drug resistant vivax malaria in Myanmar (2009-2016)
Myat Htut Nyunt et al.
MALARIA JOURNAL (2017)
Chloroquine efficacy for Plasmodium vivax in Myanmar in populations with high genetic diversity and moderate parasite gene flow
Myo Win Htun et al.
MALARIA JOURNAL (2017)
Therapeutic Responses of Plasmodium vivax Malaria to Chloroquine and Primaquine Treatment in Northeastern Myanmar
Lili Yuan et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
Characterizing Types of Human Mobility to Inform Differential and Targeted Malaria Elimination Strategies in Northeast Cambodia
Koen Peeters Grietens et al.
SCIENTIFIC REPORTS (2015)
Global extent of chloroquine-resistant Plasmodium vivax: a systematic review and meta-analysis
Ric N. Price et al.
LANCET INFECTIOUS DISEASES (2014)
Monitoring Plasmodium vivax chloroquine sensitivity along China-Myanmar border of Yunnan Province, China during 2008-2013
Hui Liu et al.
MALARIA JOURNAL (2014)
Malaria in the Greater Mekong Subregion: Heterogeneity and complexity
Liwang Cui et al.
ACTA TROPICA (2012)
A Long Neglected World Malaria Map: Plasmodium vivax Endemicity in 2010
Peter W. Gething et al.
PLOS NEGLECTED TROPICAL DISEASES (2012)
Dihydroartemisinin-Piperaquine Versus Chloroquine in the Treatment of Plasmodium vivax Malaria in Thailand: A Randomized Controlled Trial
Aung Pyae Phyo et al.
CLINICAL INFECTIOUS DISEASES (2011)
A Comparison of Two Short-Course Primaquine Regimens for the Treatment and Radical Cure of Plasmodium vivax Malaria in Thailand
Sasithon Pukrittayakamee et al.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2010)
Resistance to Therapies for Infection by Plasmodium vivax
J. Kevin Baird
CLINICAL MICROBIOLOGY REVIEWS (2009)
Plasmodium vivax resistance to chloroquine in Dawei, southern Myanmar
Jean-Paul Guthmann et al.
TROPICAL MEDICINE & INTERNATIONAL HEALTH (2008)
Therapeutic response of multidrug-resistant Plasmodium falciparum and P. vivax to chloroquine and sulfadoxine-pyrimethamine in southern Papua, Indonesia
A. Ratcliff et al.
TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE (2007)
Chloroquine-resistant Plasmodium vivax malaria in Peru
TK Ruebush et al.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2003)
Share Paper
